Wellington Management Group LLP Purchases 96,823 Shares of Addus HomeCare Corporation $ADUS

Key Points

• Wellington Management Group LLP increased its stake in Addus HomeCare Corporation by 25.8%, owning approximately 471,935 shares valued at $46.67 million.
• Analysts have a consensus rating of Buy for Addus HomeCare with an average target price of $138.38, indicating optimism for the stock's performance.
• Insider transactions included significant share sales by both the EVP and CEO, with combined sales amounting to over $3.2 million, representing notable decreases in their ownership percentages.

Wellington Management Group LLP raised its position in shares of Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 25.8% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 471,935 shares of the company's stock after purchasing an additional 96,823 shares during the quarter. Wellington Management Group LLP owned 2.57% of Addus HomeCare worth $46,670,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Natixis lifted its holdings in shares of Addus HomeCare by 111.9% in the fourth quarter. Natixis now owns 250 shares of the company's stock worth $31,000 after buying an additional 132 shares in the last quarter. Caitong International Asset Management Co. Ltd lifted its holdings in shares of Addus HomeCare by 368.3% in the first quarter. Caitong International Asset Management Co. Ltd now owns 1,255 shares of the company's stock worth $124,000 after buying an additional 987 shares in the last quarter. Bailard Inc. purchased a new position in shares of Addus HomeCare in the first quarter worth $208,000. Heritage Family Offices LLP lifted its holdings in shares of Addus HomeCare by 6.3% in the first quarter. Heritage Family Offices LLP now owns 2,417 shares of the company's stock worth $239,000 after buying an additional 143 shares in the last quarter. Finally, Private Advisor Group LLC lifted its holdings in shares of Addus HomeCare by 52.4% in the first quarter. Private Advisor Group LLC now owns 2,546 shares of the company's stock worth $252,000 after buying an additional 875 shares in the last quarter. Hedge funds and other institutional investors own 95.35% of the company's stock.

Addus HomeCare Price Performance

Addus HomeCare stock traded up $0.17 during mid-day trading on Friday, reaching $115.49. 7,333 shares of the company's stock traded hands, compared to its average volume of 189,008. The company has a market cap of $2.13 billion, a price-to-earnings ratio of 25.49, a PEG ratio of 1.76 and a beta of 0.80. The stock has a 50 day moving average of $112.03 and a two-hundred day moving average of $107.00. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.17. Addus HomeCare Corporation has a 12-month low of $88.96 and a 12-month high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings results on Monday, August 4th. The company reported $1.49 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.45 by $0.04. The company had revenue of $349.44 million for the quarter, compared to the consensus estimate of $345.71 million. Addus HomeCare had a net margin of 6.51% and a return on equity of 9.39%. Addus HomeCare's revenue was up 21.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.35 earnings per share. Equities analysts forecast that Addus HomeCare Corporation will post 4.59 earnings per share for the current year.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, CEO R Dirk Allison sold 25,000 shares of the business's stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $114.95, for a total transaction of $2,873,750.00. Following the transaction, the chief executive officer owned 166,461 shares in the company, valued at $19,134,691.95. The trade was a 13.06% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Brian Poff sold 7,739 shares of the business's stock in a transaction on Monday, August 25th. The shares were sold at an average price of $116.82, for a total transaction of $904,069.98. Following the transaction, the executive vice president owned 56,980 shares in the company, valued at $6,656,403.60. This trade represents a 11.96% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 34,310 shares of company stock worth $3,958,375 over the last quarter. Insiders own 4.50% of the company's stock.

Wall Street Analyst Weigh In

ADUS has been the topic of several research analyst reports. JMP Securities reissued a "market outperform" rating and issued a $150.00 target price on shares of Addus HomeCare in a report on Wednesday, July 16th. TD Cowen boosted their target price on shares of Addus HomeCare from $135.00 to $139.00 and gave the stock a "buy" rating in a report on Wednesday, August 6th. Barclays boosted their target price on shares of Addus HomeCare from $83.00 to $109.00 and gave the stock an "underweight" rating in a report on Tuesday, August 19th. Royal Bank Of Canada boosted their target price on shares of Addus HomeCare from $133.00 to $134.00 and gave the stock an "outperform" rating in a report on Friday, August 22nd. Finally, Wall Street Zen raised shares of Addus HomeCare from a "hold" rating to a "buy" rating in a report on Sunday, June 29th. Two investment analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has given a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Buy" and an average target price of $138.38.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.